CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection [Phase 2]

Phase 2 dose-finding trial of GSK2248761 in ART-experienced NNRTI-resistant HIV infection; the study was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: TERMINATED | Results posted: 2017-10-12